Chief Executive Officer John Presley, who didn’t disclose the type of leukemia he has, said in a letter filed with the Securities and Exchange Commission that he would undergo a 30-day treatment program at a Richmond, VA., hospital but that he expects to stay involved in the day-to-day operations of the company.
Lumber Liquidators CEO Diagnosed With ‘Treatable Form’ of Leukemia
This is a great example of enterprise risk.
Please contact us at Contact@OxfordRMG.com or 410-472-6490 to speak with one of our captive research specialists!